STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
391
13F, latest reported quarter
Conversions, 180 days
12
Codes C/M, not in net · $123.6M priced
What the filings say about CPAY
Insiders, 180 days
-$146.4M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-08-07
Planned sales (Form 144), 90 days
$113.4M
9 notices
Corpay insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CORPAY, INC. insiders sold a net $146.4M of stock across 58 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
The trade is 0.3% of the 2,466,962 shares held after it.
3 other insiders sold within 30 days.
391 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman of BOD Clarke Ronald sold about $2.8M of CPAY on Aug 25, 2026; 3 other insiders sold within 30 days and 391 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
The trade is 0.5% of the 2,454,853 shares held after it.
3 other insiders sold within 30 days.
391 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman of BOD Clarke Ronald sold about $5.0M of CPAY on Aug 25, 2026; 3 other insiders sold within 30 days and 391 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
The trade is 0.6% of the 2,439,278 shares held after it.
3 other insiders sold within 30 days.
391 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman of BOD Clarke Ronald sold about $6.4M of CPAY on Aug 25, 2026; 3 other insiders sold within 30 days and 391 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
The trade is 2.1% of the 2,388,774 shares held after it.
3 other insiders sold within 30 days.
391 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman of BOD Clarke Ronald sold about $20.8M of CPAY on Aug 25, 2026; 3 other insiders sold within 30 days and 391 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
The trade is 1.0% of the 2,364,104 shares held after it.
3 other insiders sold within 30 days.
391 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO & Chairman of BOD Clarke Ronald sold about $10.2M of CPAY on Aug 25, 2026; 3 other insiders sold within 30 days and 391 funds added in the latest 13F quarter.
58 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CPAY planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Ronald F. Clarke
Filed 2026-08-24
$88.5M
ALAN KING
Filed 2026-08-21
$1.6M
ALAN KING
Filed 2026-08-20
$7.6M
Steven T Stull
Filed 2026-08-20
$971.1K
Steven T Stull
Filed 2026-08-19
$1.6M
CPAY mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Select FinTech Portfolio
$6.0M position · as of 2026-05-31
7.4%
Amplify Digital Payments ETF
$6.7M position · as of 2026-06-30
4.4%
LYRICAL U.S. VALUE EQUITY FUND
$51.7M position · as of 2026-05-31
4.1%
StockSnips AI-Powered Sentiment US All Cap ETF
$735.9K position · as of 2026-07-31
3.8%
Victory RS Investors Fund
$2.3M position · as of 2026-06-30
3.2%
TCW Relative Value Mid Cap Fund
$4.7M position · as of 2026-07-31
2.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.4M
$2.7M
$5.0M
+10%
+32%
2024
$28.1M
$48.4M
$4.0M
+24%
+32%
2023
$2.7M
$21.1M
$3.1M
+4%
+20%
2022
$4.0M
-$24.3M
$3.9M
-33%
-21%
2021
$57.9M
$31.2M
$4.5M
-18%
-5%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $146.4M sold by insiders over 180 days, 391 funds added last quarter, $113.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.0B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CPAY
FY Dec 2025
$4.5B
FY Dec 2024
$4.0B
FY Dec 2023
$3.8B
FY Dec 2022
$3.4B
FY Dec 2021
$2.8B
Jun 2026
$1.3B
Mar 2026
$1.3B
Dec 2025
$1.2B
Sep 2025
$1.2B
Jun 2025
$1.1B
Mar 2025
$1.0B
Dec 2024
$1.0B
Sep 2024
$1.0B
At each fiscal year end
Single quarter
Net margin, TTM
+22.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CPAY
FY Dec 2025
+23.6%
FY Dec 2024
+25.3%
FY Dec 2023
+26.1%
FY Dec 2022
+27.8%
FY Dec 2021
n/a
Jun 2026
+18.5%
Mar 2026
+27.8%
Dec 2025
+21.2%
Sep 2025
+23.7%
Jun 2025
+25.8%
Mar 2025
+24.2%
Dec 2024
+23.8%
Sep 2024
+26.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.6B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CPAY
FY Dec 2025
$1.3B
FY Dec 2024
$1.8B
FY Dec 2023
$1.9B
FY Dec 2022
$603.4M
FY Dec 2021
$1.1B
Jun 2026
$1.4B
Mar 2026
-$107.7M
Dec 2025
$760.3M
Sep 2025
-$429.8M
Jun 2025
$1.1B
Mar 2025
-$118.9M
Dec 2024
$604.6M
Sep 2024
$355.0M
At each fiscal year end
Single quarter
Debt to equity
3.00x
LongTermDebt as filed 2026-06-30 (includes the current portion); equity 2026-06-30
Debt to equity CPAY
FY Dec 2025
2.58x
FY Dec 2024
2.56x
FY Dec 2023
2.05x
FY Dec 2022
2.77x
FY Dec 2021
2.09x
Jun 2026
3.00x
Mar 2026
2.95x
Dec 2025
2.58x
Sep 2025
1.99x
Jun 2025
2.07x
Mar 2025
2.37x
Dec 2024
2.56x
Sep 2024
0.81x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.17x
TTM operating cash flow over LongTermDebt as filed 2026-06-30 (includes the current portion)
Cash flow to debt CPAY
FY Dec 2025
0.15x
FY Dec 2024
0.24x
FY Dec 2023
0.31x
FY Dec 2022
0.11x
FY Dec 2021
0.20x
Jun 2026
0.17x
Mar 2026
0.15x
Dec 2025
0.15x
Sep 2025
0.16x
Jun 2025
0.26x
Mar 2025
0.19x
Dec 2024
0.24x
Sep 2024
0.80x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+30.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CPAY
FY Dec 2025
+30.5%
FY Dec 2024
+31.4%
FY Dec 2023
+33.7%
FY Dec 2022
+35.3%
FY Dec 2021
n/a
Jun 2026
+30.5%
Mar 2026
+33.8%
Dec 2025
+30.5%
Sep 2025
+29.4%
Jun 2025
+31.4%
Mar 2025
+30.3%
Dec 2024
+31.4%
Sep 2024
+33.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CPAY
FY Dec 2025
+4.8%
FY Dec 2024
+6.0%
FY Dec 2023
+6.6%
FY Dec 2022
+6.9%
FY Dec 2021
n/a
Jun 2026
+4.7%
Mar 2026
+5.2%
Dec 2025
+4.8%
Sep 2025
+5.6%
Jun 2025
+5.7%
Mar 2025
+5.9%
Dec 2024
+6.0%
Sep 2024
+6.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.9%
operating income after a 31.2% effective tax rate, over LongTermDebt as filed 2026-06-30 (includes the current portion) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CPAY
FY Dec 2025
+12.0%
FY Dec 2024
+13.3%
FY Dec 2023
+14.9%
FY Dec 2022
+13.1%
FY Dec 2021
+12.0%
Jun 2026
+12.9%
Mar 2026
+12.8%
Dec 2025
+12.0%
Sep 2025
+13.1%
Jun 2025
+13.8%
Mar 2025
+13.0%
Dec 2024
+13.3%
Sep 2024
+29.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+19.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CPAY
FY Dec 2025
+18.7%
FY Dec 2024
+20.0%
FY Dec 2023
+19.8%
FY Dec 2022
+17.9%
FY Dec 2021
+16.2%
Jun 2026
+19.9%
Mar 2026
+20.0%
Dec 2025
+18.7%
Sep 2025
+19.1%
Jun 2025
+19.5%
Mar 2025
+18.9%
Dec 2024
+20.0%
Sep 2024
+19.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
24.33x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CPAY
FY Dec 2025
20.01x
FY Dec 2024
24.21x
FY Dec 2023
21.41x
FY Dec 2022
14.78x
FY Dec 2021
22.41x
Jun 2026
20.28x
Mar 2026
17.41x
Dec 2025
20.01x
Sep 2025
19.56x
Jun 2025
22.54x
Mar 2025
24.45x
Dec 2024
24.21x
Sep 2024
22.31x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$33.7B
market value at close 2026-10-26 on 2026-07-31 shares, plus LongTermDebt as filed 2026-06-30 (includes the current portion), minus cash 2026-06-30
Enterprise value CPAY
FY Dec 2025
$28.6B
FY Dec 2024
$30.0B
FY Dec 2023
$25.7B
FY Dec 2022
$19.1B
FY Dec 2021
$22.6B
Jun 2026
$29.2B
Mar 2026
$27.6B
Dec 2025
$28.6B
Sep 2025
$26.5B
Jun 2025
$29.3B
Mar 2025
$31.1B
Dec 2024
$30.0B
Sep 2024
$22.9B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield CPAY
FY Dec 2025
+6.2%
FY Dec 2024
+7.5%
FY Dec 2023
+9.5%
FY Dec 2022
+4.5%
FY Dec 2021
+6.0%
Jun 2026
+7.5%
Mar 2026
+6.6%
Dec 2025
+6.2%
Sep 2025
+5.6%
Jun 2025
+8.2%
Mar 2025
+5.5%
Dec 2024
+7.5%
Sep 2024
+8.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.09x
P/E over trailing EPS growth of 12%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CPAY
FY Dec 2025
2.64x
FY Dec 2024
4.10x
FY Dec 2023
3.46x
FY Dec 2022
0.61x
FY Dec 2021
0.98x
Jun 2026
1.75x
Mar 2026
1.01x
Dec 2025
2.64x
Sep 2025
3.86x
Jun 2025
3.23x
Mar 2025
4.01x
Dec 2024
4.10x
Sep 2024
2.26x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CPAY ranks highest on profitability (71st percentile) and growth (67th), and lowest on insider conviction (1st), among Services peers.
Profitability
71
Inputs
Return on equity+30.5% · 86 pct, sector of 207
Return on assets+4.7% · 70 pct, sector of 269
Return on invested capital+12.9% · 46 pct, sector of 81
Return on capital employed+19.9% · 84 pct, sector of 203
Financial health
26
Inputs
Debt to equity3.00x · 8 pct, sector of 228
Cash flow to debt0.17x · 43 pct, sector of 199
Growth
67
Inputs
Revenue growth, YoY+13.9% · 67 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
1
Inputs
Net Form 4 buying (codes P and S), 180d-$146.4M · 2 pct, sector of 175
Insider buyers, 180d0 · 0 pct, sector of 180
Institutional and government
51
Inputs
Funds adding, latest quarter391 · 90 pct, sector of 243
Congress net buyers, 365d-1 · 11 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
37
Inputs
Short interest, % of float+5.5% · 34 pct, sector of 384
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+14.4% · 39 pct, sector of 227
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CPAY filings, in plain words
Are Corpay insiders buying or selling CPAY?
In the 180 days to 2026-10-28, Corpay insiders were net sellers, a net $146.4M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded CPAY?
Yes. In the year to 2026-10-28, 0 House members disclosed buying CPAY and 1 House member disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-07.
Are there planned insider sales of CPAY?
Yes. 9 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $113.4M of stock; the latest, by Ronald F. Clarke, was filed 2026-08-24.
Read the full summary
In the 180 days to 2026-10-28, Corpay insiders were net sellers of CPAY, a net $146.4M across purchases and sales reported on Form 4 by 5 sellers. None of the 42 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 0 members of Congress disclosed buying CPAY and 1 member disclosed selling it; the latest on record is a sale by April McClain Delaney dated 2026-08-07. Insiders filed 9 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $113.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.